Oxidative Stress in the Tumor Microenvironment and Its Relevance to Cancer Immunotherapy
Open accessThe DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Abstract
It has been well-established that cancer cells are under constant oxidative stress, as reflected by elevated basal level of reactive oxygen species (ROS), due to increased metabolism driven by aberrant cell growth. Cancer cells can adapt to maintain redox homeostasis through a variety of mechanisms. The prevalent perception about ROS is that they are one of the key drivers promoting tumor initiation, progression, metastasis, and drug resistance. Based on this notion, numerous antioxidants that aim to mitigate tumor oxidative stress have been tested for cancer prevention or treatment, although the effectiveness of this strategy has yet to be established. In recent years, it has been increasingly appreciated that ROS have a complex, multifaceted role in the tumor microenvironment (TME), and that tumor redox can be targeted to amplify oxidative stress inside the tumor to cause tumor destruction. Accumulating evidence indicates that cancer immunotherapies can alter tumor redox to intensify tumor oxidative stress, resulting in ROS-dependent tumor rejection. Herein we review the recent progresses regarding the impact of ROS on cancer cells and various immune cells in the TME, and discuss the emerging ROS-modulating strategies that can be used in combination with cancer immunotherapies to achieve enhanced antitumor effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–256 of 256
Tinsley, H. N., Gary, B. D., Keeton, A. B., Lü, W., Li, Y., & Piazza, G. A. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0095 · Cited by 107
Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials
Nauman, G., Gray, J. C., Parkinson, R., Levine, M., & Paller, C. J. (2018) · Antioxidants · doi:10.3390/antiox7070089 · Cited by 107
ROS‐Responsive N‐Alkylaminoferrocenes for Cancer‐Cell‐Specific Targeting of Mitochondria
Reshetnikov, V., Daum, S., Janko, C., Karawacka, W., Tietze, R., Alexiou, C., Paryzhak, S. Y., Dumych, T. I., Bilyy, R. O., Tripal, P., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201805955 · Cited by 107
Chiu, W. C., Luo, S.-J., Chen, C., Cheng, J., Hsieh, C.-Y., Wang, C., Huang, W., Su, W., & Lin, C. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.016 · Cited by 106
Redox Regulation of MAP Kinase Phosphatase 3
Seth, D., & Rudolph, J. (2006) · Biochemistry · doi:10.1021/bi060157p · Cited by 105
Metastasis and Oxidative Stress: Are Antioxidants a Metabolic Driver of Progression?
Peiris‐Pagès, M., Martinez‐Outschoorn, U., Sotgia, F., & Lisanti, M. P. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.008 · Cited by 104
Efimova, O., Szankasi, P., & Kelley, T. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016013 · Cited by 101
Shenoy, N. K., Bhagat, T. D., Cheville, J. C., Lohse, C. M., Bhattacharyya, S., Tischer, A., Machha, V. R., Gordon-Mitchell, S., Choudhary, G. S., Wong, L.-F., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci98747 · Cited by 99
Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells
Yang, Y., Neo, S., Chen, Z., Cui, W., Chen, Y., Guo, M., Wang, Y., Xu, H., Kurzay, A., Alici, E., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137585 · Cited by 98
Nagane, M., Kanai, E., Shibata, Y., Shimizu, T., Yoshioka, C., Maruo, T., & Yamashita, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195151 · Cited by 95
De Boo, S., Kopecka, J., Brusa, D., Gazzano, E., Matera, L., Ghigo, D., Bosia, A., & Riganti, C. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-108 · Cited by 93
Teoh-Fitzgerald, M. L., Fitzgerald, M. P., Zhong, W., Askeland, R. W., & Domann, F. E. (2014) · Oncogene · doi:10.1038/onc.2012.582 · Cited by 92
Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane
Iida, Y., Okamoto-Κatsuyama, M., Maruoka, S., Mizumura, K., Shimizu, T., Shikano, S., Hikichi, M., Takahashi, M., Tsuya, K., Okamoto, S., et al. (2020) · Oncology Letters · doi:10.3892/ol.2020.12332 · Cited by 87
Habtetsion, T. G., Ding, Z., Pi, W., Li, T., Lu, C., Chen, T., Xi, C., Spartz, H., Liu, K., Hao, Z., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.012 · Cited by 83
Self-citationPritchard, R., Rodríguez‐Enríquez, S., Pacheco-Velázquez, S. C., Bortnik, V., Moreno‐Sánchez, R., & Ralph, S. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.05.013 · Cited by 82
Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy
Hussain, M., Javeed, A., Ashraf, M., Al-Zaubai, N., Stewart, A. G., & Mukhtar, M. M. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.02.003 · Cited by 81
Scheffel, M. J., Scurti, G. M., Simms, P. E., Garrett-Mayer, E. S., Mehrotra, S., Nishimura, M. I., & Voelkel‐Johnson, C. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0587 · Cited by 79
Rodríguez-Hernández, M. A., de la Cruz‐Ojeda, P., López-Grueso, M. J., Navarro‐Villarán, E., Requejo-Aguilar, R., Castejón‐Vega, B., Negrete, M., Gallego, P., Vega-Ochoa, Á., Víctor, V. M., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101510 · Cited by 77
Li, N., Lee, K., Xi, Y., Zhu, B., Gary, B. D., Ramírez‐Alcántara, V., Gurpinar, E., Canzoneri, J. C., Fajardo, A., Sigler, S. C., et al. (2014) · Oncogene · doi:10.1038/onc.2014.94 · Cited by 72
Ostrand‐Rosenberg, S., Beury, D. W., Parker, K. H., & Horn, L. A. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02388-8 · Cited by 72
xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction
Cobler, L., Zhang, H., Suri, P., Park, C., & Timmerman, L. A. (2018) · Oncotarget · doi:10.18632/oncotarget.25794 · Cited by 71
Raza, H., & John, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036325 · Cited by 68
Ou, Y., Yang, C., Cheng, C., Raung, S., Hung, Y.-Y., & Chen, C. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.071 · Cited by 68
Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes
Nishikawa, M., Hyoudou, K., Kobayashi, Y., Umeyama, Y., Takakura, Y., & Hashida, M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.017 · Cited by 67
Liu, J., Du, J., Zhang, Y., Sun, W., Smith, B. J., Oberley, L. W., & Cullen, J. J. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.105 · Cited by 67
How the redox state regulates immunity
Mullen, L., Mengozzi, M., Hanschmann, E.-M., Alberts, B. M., & Ghezzi, P. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.022 · Cited by 67
Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells.
Adachi, M., Sakamoto, H., Kawamura, R., Wang, W., Imai, K., & Shinomura, Y. (2007) · PubMed · doi:10.14670/hh-22.437 · Cited by 64
The Cellular Redox Environment Alters Antigen Presentation
Trujillo, J. A., Croft, N. P., Dudek, N. L., Channappanavar, R., Theodossis, A., Webb, A. I., Dunstone, M. A., Illing, P. T., Butler, N. S., Fett, C., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.573402 · Cited by 61
Liu, Y., Wei, J., Guo, G., & Zhou, J. (2015) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2015.1059442 · Cited by 60
Ralph, S. J., Pritchard, R., Rodríguez‐Enríquez, S., Moreno‐Sánchez, R., & Ralph, R. K. (2015) · Pharmaceuticals · doi:10.3390/ph8010062 · Cited by 57
Li, N., Chen, X., Zhu, B., Ramírez‐Alcántara, V., Canzoneri, J. C., Lee, K., Sigler, S. C., Gary, B. D., Li, Y., Zhang, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4741 · Cited by 55
Tse, A. K., Cao, H., Cheng, C.-Y., Kwan, H. Y., Yu, H., Fong, W. F., & Yu, Z. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.471 · Cited by 55
Sulindac Enhances the Killing of Cancer Cells Exposed to Oxidative Stress
Marchetti, M., Resnick, L., Gamliel, E., Kesaraju, S., Weissbach, H., & Binninger, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005804 · Cited by 55
Chen, W., Fan, H., Balakrishnan, K., Wang, Y., Sun, H., Fan, Y., Gandhi, V. V., Arnold, L. A., & Peng, X. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00559 · Cited by 55
RelB Expression Determines the Differential Effects of Ascorbic Acid in Normal and Cancer Cells
Wei, X., Xu, Y., Xu, F., Chaiswing, L., Schnell, D., Noel, T. J., Wang, C., Chen, J., Clair, D. K. S., & Clair, W. H. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0785 · Cited by 54
Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells
Roy, D. (2006) · Frontiers in Bioscience · doi:10.2741/1845 · Cited by 52
Oxidative stress can alter the antigenicity of immunodominant peptides
Weiskopf, D., Schwanninger, A., Weinberger, B., Almanzar, G., Parson, W., Buus, S., Lindner, H., & Grubeck‐Loebenstein, B. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0209065 · Cited by 52
Harris, I. S., Treloar, A. E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K. C., Yung, K. Y., Brenner, D., Knobbe-Thomsen, C. B., Cox, M. A., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.01.009 · Cited by 52
Gong, Y., Chen, M., Tan, Y., Shen, J., Jin, Q., Deng, W., Sun, J., Wang, C., Liu, Z., & Chen, Q. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c13943 · Cited by 51
Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions
Kesarwani, P., Al-Khami, A. A., Scurti, G. M., Thyagarajan, K., Kaur, N., Husain, S., Fang, Q., Naga, O. S., Simms, P. E., Beeson, G. C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1084 · Cited by 48
Activity of aminoferrocene-based prodrugs against prostate cancer
Schikora, M., Резніков, А. Г., Chaykovskaya, L., Sachinska, O., Polyakova, L., & Mokhir, A. A. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.07.013 · Cited by 47
Glutathione Reductase Is Inhibited by Acetaminophen-glutathione Conjugate In Vitro
Roušar, T., PAŘÍK, P., Kučera, O., Bartoš, M., & Červinková, Z. (2010) · Physiological Research · doi:10.33549/physiolres.931744 · Cited by 47
Scheffel, M. J., Scurti, G. M., Wyatt, M. M., Garrett-Mayer, E. S., Paulos, C. M., Nishimura, M. I., & Voelkel‐Johnson, C. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2120-5 · Cited by 47
Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy
Firczuk, M., Bajor, M., Graczyk‐Jarzynka, A., Fidyt, K., Góral, A., & Zagożdżon, R. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.037 · Cited by 46
Majchrzak, K., Nelson, M. H., Bowers, J. S., Bailey, S. R., Wyatt, M. M., Wrangle, J. M., Rubinstein, M. P., Varela, J. C., Li, Z., Himes, R. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90547 · Cited by 43
Verrastro, I., Tveen‐Jensen, K., Woscholski, R., Spickett, C. M., & Pitt, A. R. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.004 · Cited by 42
Neuroglobin: A Novel Player in the Oxidative Stress Response of Cancer Cells
Fiocchetti, M., Fernandez, V. S., Montalesi, E., & Marino, M. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6315034 · Cited by 37
Fletcher, R., Tong, J., Risnik, D., Leibowitz, B. J., Wang, Y., Concha‐Benavente, F., DeLiberty, J. M., Stolz, D. B., Pai, R. K., Ferris, R. L., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01687-8 · Cited by 34
Epidermal growth factor-induced hydrogen peroxide production is mediated by dual oxidase 1
Sirokmány, G., Pató, A., Zana, M., Donkó, Á., Bíró, A., Nagy, P., & Geiszt, M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.05.028 · Cited by 30
Zhang, X., Lee, S., Min, K., McEntee, M. F., Jeong, J. B., Li, Q., & Baek, S. J. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0220 · Cited by 27
Ralph, S. J., Nozuhur, S., Moreno‐Sánchez, R., Enr��quez, S. R., & Pritchard, R. (2018) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.42 · Cited by 25
Zhang, Y. (2011) · Oncology Reports · doi:10.3892/or.2011.1297 · Cited by 23
Yoo, H. J., Liu, Y., Wang, L., Schubert, M., Hoffmann, J., Wang, S., Neuber, B., Hückelhoven‐Krauss, A., Gern, U., Schmitt, A., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102469 · Cited by 20
Fernandez, V. S., Cipolletti, M., Ascenzi, P., Marino, M., & Fiocchetti, M. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7870 · Cited by 19
Tang, J., Ramis‐Cabrer, D., Wang, X., & Barreiro, E. (2019) · Cancers · doi:10.3390/cancers11091301 · Cited by 17
Fiocchetti, M., Fernandez, V. S., Segatto, M., Leone, S., Cercola, P., Massari, A., Cavaliere, F., & Marino, M. (2020) · Cancers · doi:10.3390/cancers12092451 · Cited by 12
Cited by
Free radicals and their impact on health and antioxidant defenses: a review
Chandimali, N., Bak, S. G., Park, E. H., Lim, H.-J., Won, Y.-S., Kim, E.-K., Park, S.-I., & Lee, S. J. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02278-8 · Cited by 669
Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend?
Kuo, C.-L., Ponneri Babuharisankar, A., Lin, Y.-C., Lien, H.-W., Lo, Y. K., Chou, H.-Y., Tangeda, V., Cheng, L.-C., Cheng, A. N., & Lee, A. Y.-L. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00859-2 · Cited by 351
Jiang, Y., Huo, Z., Qi, X., Zuo, T., & Wu, Z. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0374 · Cited by 276
H 2 S-Prdx4 axis mitigates Golgi stress to bolster tumor-reactive T cell immunotherapeutic response
Oberholtzer, N., Chakraborty, P., Kassir, M. F., Dressman, J., Das, S., Mills, S., Comte-Walters, S., Gooz, M., Choi, S., Parikh, R. Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp1152 · Cited by 24
“Multiple studies have identified oxidative and ER stress within the tumor microenvironment (TME) as major contributors of immune cell dysfunction and immune evasion ( 12 – 16 ).”
Metadata
- Authors
- Aboelella, N. S., Brandle, C., Kim, T., Ding, Z.-C., & Zhou, G.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-02-27
- Volume
- 13
- Issue
- 5
- Pages
- 986
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W3133766872
- Cited by
- 286
- References
- 256
- FWCI
- 9.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.